Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
34 Ergebnisse
| MB80XF |  | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 120,710 | 132,700 | 1,570 | 59,282 % | - | Morgan Stanley | |
| MD2MNN | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 140,170 | 140,170 | 1,733 | 56,990 % | - | Morgan Stanley | |
| MD328F | | BeiGene Ltd. (ADRs)/Faktor/Long [3]/MS | - | - | call | BeiGene Ltd. (ADRs) | 217,887 | 228,790 | 2,878 | 29,797 % | - | Morgan Stanley | |
| MG22CE | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 122,816 | 122,816 | 1,581 | 62,315 % | - | Morgan Stanley | |
| MG34NZ | | BeiGene Ltd. (ADRs)/Faktor/Long [5]/MS | - | - | call | BeiGene Ltd. (ADRs) | 261,475 | 274,550 | 4,704 | 15,756 % | - | Morgan Stanley | |
| MG7KE7 | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 152,188 | 167,300 | 1,854 | 48,665 % | - | Morgan Stanley | |
| MG7XKN | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 162,747 | 178,910 | 1,968 | 45,103 % | - | Morgan Stanley | |
| MG9FVK | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 172,604 | 189,740 | 2,090 | 41,780 % | - | Morgan Stanley | |
| MG9FWP | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 189,864 | 189,864 | 2,349 | 41,742 % | - | Morgan Stanley | |
| MJ8CFY | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 205,252 | 205,252 | 2,629 | 37,020 % | - | Morgan Stanley | |
| MJ8U9Z | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 186,275 | 204,770 | 2,302 | 37,168 % | - | Morgan Stanley | |
| MJ8V0F | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 216,286 | 216,286 | 2,885 | 33,634 % | - | Morgan Stanley | |
| MK1TWC | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 180,266 | 180,266 | 2,188 | 44,687 % | - | Morgan Stanley | |
| MK6WXM | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 201,360 | 221,350 | 2,561 | 32,080 % | - | Morgan Stanley | |
| MK6X8Z | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 232,571 | 232,571 | 3,366 | 28,637 % | - | Morgan Stanley | |
| MK7AJZ | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 221,117 | 243,070 | 3,032 | 25,416 % | - | Morgan Stanley | |
| MK7QDV | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 253,852 | 253,852 | 4,298 | 22,107 % | - | Morgan Stanley | |
| MK7ZT1 | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 230,379 | 253,250 | 3,346 | 22,292 % | - | Morgan Stanley | |
| MM0WK3 | | BeiGene Ltd. (ADRs)/Faktor/Short [3]/MS | - | - | put | BeiGene Ltd. (ADRs) | 435,683 | 413,890 | 3,019 | 26,999 % | - | Morgan Stanley | |
| MM1Z6H | | BeiGene Ltd. (ADRs)/Faktor/Short [4]/MS | - | - | put | BeiGene Ltd. (ADRs) | 408,453 | 388,020 | 4,018 | 19,061 % | - | Morgan Stanley | |
| MM2KYV | | BeiGene Ltd. (ADRs)/KO/Put [endlos]/MS | - | - | put | BeiGene Ltd. (ADRs) | 397,442 | 397,442 | 4,416 | 21,952 % | - | Morgan Stanley | |
| MM4E53 | | BeiGene Ltd. (ADRs)/Faktor/Short [5]/MS | - | - | put | BeiGene Ltd. (ADRs) | 392,114 | 372,500 | 4,994 | 14,299 % | - | Morgan Stanley | |
| MN337Y | | BeiGene Ltd. (ADRs)/Faktor/Short [2]/MS | - | - | put | BeiGene Ltd. (ADRs) | 490,143 | 465,630 | 2,006 | 42,875 % | - | Morgan Stanley | |
| MN8NH1 | | BeiGene Ltd. (ADRs)/Faktor/Short [8]/MS | - | - | put | BeiGene Ltd. (ADRs) | 367,607 | 349,220 | - | 7,156 % | - | Morgan Stanley | |
| MN8NH2 | | BeiGene Ltd. (ADRs)/Faktor/Short [10]/MS | - | - | put | BeiGene Ltd. (ADRs) | 359,438 | 341,460 | - | 4,774 % | - | Morgan Stanley | |
| MN8NK4 | | BeiGene Ltd. (ADRs)/Faktor/Long [8]/MS | - | - | call | BeiGene Ltd. (ADRs) | 285,988 | 300,290 | - | 7,858 % | - | Morgan Stanley | |
| MN8NK5 | | BeiGene Ltd. (ADRs)/Faktor/Long [10]/MS | - | - | call | BeiGene Ltd. (ADRs) | 294,159 | 308,870 | - | 5,226 % | - | Morgan Stanley | |
| MN95UH | | BeiGene Ltd. (ADRs)/Faktor/Long [2]/MS | - | - | call | BeiGene Ltd. (ADRs) | 163,422 | 171,600 | - | 47,346 % | - | Morgan Stanley | |
| MR101N | | BeiGene Ltd. (ADRs)/Faktor/Long [5]/MS | - | - | call | BeiGene Ltd. (ADRs) | 261,475 | 274,550 | - | 15,756 % | - | Morgan Stanley | |
| MR1FCB | | BeiGene Ltd. (ADRs)/Faktor/Long [3]/MS | - | - | call | BeiGene Ltd. (ADRs) | 217,896 | 228,800 | - | 29,794 % | - | Morgan Stanley | |
| MR1FCC | | BeiGene Ltd. (ADRs)/Faktor/Long [4]/MS | - | - | call | BeiGene Ltd. (ADRs) | 245,133 | 257,390 | - | 21,022 % | - | Morgan Stanley | |
| MR2QPY | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 251,299 | 276,250 | 4,210 | 15,235 % | - | Morgan Stanley | |
| MR2QXQ | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 276,428 | 276,428 | 6,006 | 15,180 % | - | Morgan Stanley | |
| MR4DGB | | BeiGene Ltd. (ADRs)/KO/Call [endlos]/MS | - | - | call | BeiGene Ltd. (ADRs) | 300,135 | 300,135 | - | 7,906 % | - | Morgan Stanley |